Your browser doesn't support javascript.
loading
Use of durvalumab in stage III non-small-cell lung cancer based on eligibility for the PACIFIC study.
Boys, Emma; Gao, Bo; Hui, Rina; da Silva, Inês; Hau, Eric; Gee, Harriet; Nagrial, Adnan.
Affiliation
  • Boys E; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead, New South Wales, Australia.
  • Gao B; Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, New South Wales, Australia.
  • Hui R; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
  • da Silva I; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead, New South Wales, Australia.
  • Hau E; Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, New South Wales, Australia.
  • Gee H; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
  • Nagrial A; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead, New South Wales, Australia.
Thorac Cancer ; 14(6): 563-572, 2023 02.
Article in En | MEDLINE | ID: mdl-36627112
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Thorac Cancer Year: 2023 Document type: Article Affiliation country: Australia Country of publication: Singapore
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Thorac Cancer Year: 2023 Document type: Article Affiliation country: Australia Country of publication: Singapore